CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Kidney disease is recognized as a major global health burden. However, nationwide studies on hospitalization outcomes related to acute kidney injury (AKI) and chronic kidney disease (CKD) in Poland are lacking. The objective of this study was to identify risk factors for in-hospital mortality and prolonged length of stay among patients hospitalized due to AKI or CKD in Poland. It is the first nationwide analysis to evaluate these outcomes in this patient population.

Material and methods:
This is a retrospective nationwide analysis of hospital discharge records of adult patients hospitalized due to a primary diagnosis of AKI (ICD-10 N17) or CKD (ICD-10 N18) between 2017 and 2021 in Poland. Risk factors for in-hospital mortality (death during hospitalization) and prolonged stay (≥ 8 days) were identified using logistic regression.

Results:
Among 327 833 eligible hospitalizations, AKI accounted for 143 534 cases (mortality 21.3%; prolonged hospitalization 48%) and CKD for 184 299 cases (mortality 4.9%; prolonged hospitalization 24.7%). Significant risk factors for in-hospital mortality included female sex, age ≥ 70 years, neoplasms, and cardiovascular, respiratory, and digestive system diseases for both AKI and CKD. Prolonged hospitalization was associated with female sex, age ≥ 70 years, and hematologic, cardiovascular, respiratory, and digestive system diseases for AKI; and with age ≥ 70 years, neoplasms, and hematologic, endocrine, cardiovascular, respiratory, and digestive system diseases for CKD.

Conclusions:
The study identified key risk factors for in-hospital mortality and prolonged hospitalization among patients with AKI or CKD. The findings may guide clinical risk stratification.
REFERENCES (48)
1.
World Health Organization. The top 10 causes of death [Internet]. World Health Organization. 2024 [cited 2025 Apr 4]. Available from: https://www.who.int/news-room/....
 
2.
Lameire NH, Levin A, Kellum JA, et al. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 2021; 100: 516-26.
 
3.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012; 2: 1-138.
 
4.
Institute for Health Metrics and Evaluation. Global Health Data Exchange (GHDx) [Internet]. Institute for Health Metrics and Evaluation. University of Washington; 2021 [cited 2025 Apr 4]. Available from: https://vizhub.healthdata.org/....
 
5.
Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication – worldwide more than 850 million individuals have kidney diseases. Kidney Int 2019; 96: 1048-50.
 
6.
Mehta RL, Cerdá J, Burdmann EA, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 2015; 385: 2616-43.
 
7.
Paciej-Gołębiowska P, Kurnatowska I, Maniecka-Bryła I, Pikala M. Twenty-year mortality trends in patients with kidney disease in poland with the use of the years of life lost measure, 2000–2019. Int J Environ Res Public Health 2022; 19: 2649.
 
8.
Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024; 105: S117-314.
 
9.
Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet 2017; 389: 1238-52.
 
10.
Matuszkiewicz-Rowińska J, Małyszko J. Acute kidney injury, its definition, and treatment in adults: guidelines and reality. Pol Arch Intern Med 2020; 130: 1074-80.
 
11.
Mercado MG, Smith DK, Guard EL. Acute Kidney injury: diagnosis and management. Am Fam Physician 2019; 100: 687-94.
 
12.
Schrauben SJ, Chen HY, Lin E, et al. Hospitalizations among adults with chronic kidney disease in the United States: a cohort study. PLoS Med 2020; 17: e1003470.
 
13.
López-Bueno JA, Díaz J, Padrón-Monedero A, et al. Short-term impact of extreme temperatures, relative humidity and air pollution on emergency hospital admissions due to kidney disease and kidney-related conditions in the Greater Madrid area (Spain). Sci Total Environ 2023; 903: 166646.
 
14.
Wong E, Ballew SH, Daya N, et al. Hospitalization risk among older adults with chronic kidney disease. Am. J Nephrol 2019; 50: 212-20.
 
15.
Wu L, Hu Y, Yuan B, et al. Which risk predictors are more likely to indicate severe AKI in hospitalized patients?. Int J Med Inform 2020; 143: 104270.
 
16.
Poznańska A, Goryński P, Seroka W, et al. Nationwide General Hospital Morbidity Study as a source of data about Polish population health. Przegl Epidemiol 2019; 73: 69-80.
 
17.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision [Internet]. Geneva: World Health Organization; 2019 [cited 2025 Mar 9]. Available from: https://icd.who.int/browse10/2....
 
18.
Domańska-Poboża J, Kapica Ł, Kanecki K, et al. Hospitalizations of patients with rheumatoid arthritis in Polish intensive care units or cardiac intensive care units in the years 2011–2021: a population study. Pol Arch Intern Med 2025; 135: 16913.
 
19.
Bogdan M, Nitsch-Osuch A, Kanecki K, et al, Samel-Ko­walik P. Sarcoidosis among hospitalized patients in Poland: a study based on a national hospital registry. Pol Arch Intern Med 2019; 129: 580-5.
 
20.
Jankowski M, Bochenek B, Wieczorek J, et al. Epidemiological characteristics of 101,471 patients hospitalized with chronic obstructive pulmonary disease (COPD) in Poland in 2019: multimorbidity, duration of hospitalization, in-hospital mortality. Adv Respir Med 2023; 91: 368-82.
 
21.
Kanecki K, Goryński P, Kowalczyk M, et al. Long-term trends in intensive care unit hospitalizations in Poland: study based on the National Hospital Registry, 2012-2021. Arch Med Sci 2024 DOI: https://doi.org/10.5114/aoms/1....
 
22.
Seabold S, Perktold J. Statsmodels: econometric and statistical modeling with python. Proceedings of the 9th Python in Science Conference; 2010 Jul 28–31; Austin, TX. Austin (TX): SciPy; 2010.
 
23.
Coccia M, Benati I. Negative effects of high public debt on health systems facing pandemic crisis: lessons from COVID-19 in Europe to prepare for future emergencies. AIMS Public Health 2024; 11: 477-98.
 
24.
Guttman-Kenney B, Kluender R, Mahoney N, et al. Trends in medical debt during the COVID-19 pandemic. JAMA Health Forum 2022; 3: e221031.
 
25.
Deng D, Liang A, Chui JN, et al. The COVID-19 pandemic and access to health care in people with chronic kidney disease: a systematic review and meta-analysis. Nephrology 2022; 27: 410-20.
 
26.
Sękowski K, Grudziąż-Sękowska J, Goryński P, et al. Epidemiological analysis of diabetes-related hospitalization in Poland before and during the COVID-19 Pandemic, 2014-2020. Int J Environ Res Public Health 2022; 19: 10030.
 
27.
Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol 2018; 14: 151-64.
 
28.
Hoste EAJ, Kellum JA, Selby NM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol 2018; 14: 607-25.
 
29.
Neugarten J, Golestaneh L. Female sex reduces the risk of hospital-associated acute kidney injury: a meta-analysis. BMC Nephrol 2018; 19: 314.
 
30.
Hallan SI, Matsushita K, Sang Y, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308: 2349-60.
 
31.
Tsai WC, Wu HY, Peng YS, et al. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine 2016; 95: e3013.
 
32.
Ellam T, Twohig H, Khwaja A. Chronic kidney disease in elderly people: disease or disease label? BMJ 2016; 352: h6559.
 
33.
Choręza P, Owczarek AJ, Kruk W, Chudek J. The epidemiology of the most frequent cancers in Poland in 2015-2021 and the impact of the COVID-19 pandemic on cancer incidence. Arch Public Health 2024; 82: 49.
 
34.
Munch PV, Nørgaard M, Jensen SK, et al. Risk of and mortality after acute kidney injury following cancer treatment: a cohort study. Cancer Med 2025; 14: e70646.
 
35.
Gudsoorkar P, Langote A, Vaidya P, Meraz-Muñoz AY. Acute kidney injury in patients with cancer: a review of onconephrology. Adv Chronic Kidney Dis 2021; 28: 394-401.e1.
 
36.
Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol 2010; 23: 253-62.
 
37.
Waszczuk-Gajda A, Vesole DH, Małyszko J, et al. Real-world prognostic factors in autotransplanted multiple myeloma patients with severe renal impairment: study of the Polish Myeloma Study Group. Arch Med Sci 2024; 20: 1864-73.
 
38.
Gembillo G, Calimeri S, Tranchida V, et al. Lung dysfunction and chronic kidney disease: a complex network of multiple interactions. J Pers Med 2023; 13: 286.
 
39.
Paladino JD, Hotchkiss JR, Rabb H. Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease? Microvasc Res 2009; 77: 8-12.
 
40.
Alge J, Dolan K, Angelo J, et al. Two to tango: kidney-lung interaction in acute kidney injury and acute respiratory distress syndrome. Front Pediatr 2021; 9: 744110.
 
41.
Mani AP, Shanmugapriya K, Sundar R, Yadav S. Pulmonary manifestations at different stages in the chronic kidney disease: an observational study. Cureus 2023; 15: e39235.
 
42.
Marx-Schütt K, Cherney DZI, Jankowski J, et al. Cardiovascular disease in chronic kidney disease. Eur Heart J 2025; 46: 2148-60.
 
43.
Odutayo A, Wong CX, Farkouh M, et al. AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol 2017; 28: 377-87.
 
44.
Yao S, Xu D. Relationships between blood concentrations of cadmium, lead, mercury, selenium, and manganese and the risk of chronic kidney disease: a cross-sectional study based on NHANES 2011-2018. Arch Med Sci 2024; 20: 1822-30.
 
45.
Kim KN, Shin MK, Lim YH, et al. Associations of cold exposure with hospital admission and mortality due to acute kidney injury: a nationwide time-series study in Korea. Sci Total Environ 2023; 863: 160960.
 
46.
Leite KM, Long AM, Ostroff ML, et al. A review of the renoprotective effects of novel antidiabetic agents J Pharm Pract 2021; 34: 141-8.
 
47.
Gerdes C, Müller N, Wolf G, Busch M. Nephroprotective properties of antidiabetic drugs. J Clin Med 2023; 12: 3377.
 
48.
Kamińska A, Pinkas J, Goryński P, Jankowski M. A national registry-based epidemiological study to evaluate 395 646 patients hospitalized due to eye diseases in Poland in 2019. Med Sci Monit 2023; 29: e939351.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top